Brian Dugan, Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN discusses the more than three billion biological samples tested milestone and the more than one million samples with its next-generation sequencing (NGS) panels.
Brian Dugan is the Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN. Since joining QIAGEN, has lead commercialization of genomics solutions across application areas and modalities . These developments span ultra-sensitive targeted methylation chemistry for liquid biopsy testing, single-cell RNA detection solutions, microbiology and infectious disease testing, and market-leading miRNA NGS solutions. Brian has worked in the genomics space since 2012 and has a MS in Biochemistry and Molecular Biology from Georgetown University.